Collectively, these findings suggest that LMP1 can drive NPC progression by stimulating the expression of many immunomodulatory molecules, which creates a TME with a chronic inflammatory infiltrate. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.